OncoDaily Newsletter

Subscribe to our newsletter

Subscribe

10 Must-Read Posts In Radiotherapy This Week: August 24-30

The Invisible Patient: When Caring for Cancer Becomes Its Own Toxicity

RATIONALE-306: Tislelizumab Plus Chemotherapy Shows Sustained 3-Year Survival Benefit in Advanced ESCC

Busy Philipps Reveals Oligodendroglioma Diagnosis: Symptoms, Treatment and Prognosis

Bob Li Highlights a Major Step Toward More Equitable Cancer Trials

Oncology News, Insights, Stories by OncoDaily

Gevorg Tamamyan
Not To Miss

OncoDaily Editor-in-Chief Gevorg Tamamyan Awarded 2026 Global Health Catalyst Distinguished Leader Award

Camizestrant
Breast Oncology

FDA Grants Accelerated Approval to Camizestrant for ESR1-Mutated Advanced Breast Cancer

Leuko 2026
Hematology

Highlights From LeukO 2026: Global Virtual Congress on Leukemias, Day 2

King Hussein Cancer Center Launches Survey to Strengthen Collaborative Oncology Research in the Arab World

Sacrificing the Future to Save the Present: Intergenerational Financial Toxicity and Treatment Abandonment in Tunisia

Thomas E. Stinchcombe Named New Editor-in-Chief of Journal of Clinical Oncology

Tommy John and Bladder Cancer: The Inspiring Story of a Baseball Legend Who Changed Sports Medicine

E. Anders Kolb: Nearly 26 Million Years of Life Saved Through Blood Cancer Advances

Applying Metastatic Renal Cell Carcinoma Guidelines Across Resource Settings: From Recommendations to Deliverable Care

Al-Ola Abdallah: The Price of Publishing Science is Skyrocketing

Voices
Sandrine Piret-Gerard

Sandrine Piret-Gerard: Argenx Seeks New Talent to Drive Innovation in Immunology

Hannah Levy: Rethinking CAR-T and the Future of B-Cell Lymphoma Care

Joshua Richter: Honoring a Legacy That Continues to Influence Medicine

Sumanta K. Pal: IUCS26 Highlights the Rapid Evolution of Prostate Cancer Therapy

Valerie Chew: Advances in Liver Cancer Research at ILCA 2026

Humaid Al-Shamsi: Burjeel Cancer Institute Advances Care for Complex Solid Tumors

Yan Leyfman: Rethinking Treatment Strategies in Muscle-Invasive Bladder Cancer

FDA Approvals
Ziihera

FDA Approves Ziihera With and Without Tislelizumab Plus Chemotherapy for First-Line HER2-Positive Gastroesophageal Adenocarcinoma

FDA Approves OncoSil Device for Distal Cholangiocarcinoma

FDA Grants Accelerated Approval to Bristol Myers Squibb’s Zenbexus Plus Daratumumab and Hyaluronidase-fihj and Dexamethasone for Multiple Myeloma

FDA Grants Priority Review to RYBREVANT FASPRO After Promising 42% Response in Head and Neck Cancer

FDA Approved Subcutaneous Isatuximab: Advancing Anti-CD38 Therapy Delivery in Multiple Myeloma

FDA Approves Belzutifan Plus Pembrolizumab for Adjuvant RCC

FDA Approved Decnupaz, the First ADC for Adults With BPDCN

OncoDaily 100
100 Influential Women in Oncology

100 Influential Women in Oncology in 2026: Key Opinion Leaders in Social Media and Beyond

100 Influential Women in Oncology in 2026: Key Opinion Leaders in Social Media and Beyond

100 Influential People in Oncology 2026 – Nominations are Open!

100 Influential Cancer Survivors on Social Media: 2026 Edition

100 Xfluencers in Prostate Cancer: Key Opinion Leaders to follow on X (Twitter) in 2025

The 100 Most Influential CEOs in Oncology in 2025 (Full List)

The 100 Most Influential People in Oncology in 2025 (Full List)

Celebrities and Cancer

OncoCalendar

2026 Binaytara Northwest Women’s Cancer Conference

Binaytara

12 Sep
Women’s Cancer Conference

Rare Cancers Conference 2026: Advances in Diagnosis, Genomics, and Targeted Therapies

Binaytara

14 Nov
Rare Cancers Conference

The Future We Choose Together: Turning Global Evidence into Local Action

City Cancer Challenge

08 Sep
Global Evidence

ESMO Deep Dive: Are We Defeating Cervical Cancer?

European Society For Medical Oncology (ESMO)

18 Nov
ESMO Deep Dive

ESMO Preceptorship on Prostate Cancer 2027

European Society For Medical Oncology (ESMO)

13 Jan
Preceptorship on Prostate Cancer

Immune-oncology
RATIONALE-306: Tislelizumab Plus Chemotherapy Shows Sustained 3-Year Survival Benefit in Advanced ESCC

RATIONALE-306: Tislelizumab Plus Chemotherapy Shows Sustained 3-Year Survival Benefit in Advanced ESCC

Etentamig and the Next Wave of Immune Engagers in Multiple Myeloma

Dana-Farber Study Links CDK2 Activity With Response to Immune Checkpoint Blockade

Talquetamab in R/R Multiple Myeloma: Real-World Analysis From the IMWG Immunotherapy Registry

What Happens If CAR T-Cell Therapy Fails? Relapse, Refractory Disease, and Next Treatment Options

Anti-CD7 CAR T-Cell Therapy Shows Promising CNS Activity in Relapsed or Refractory T-ALL/LBL

ctDNA and MRD in NSCLC: Emerging Clinical Applications in the Immunotherapy Era

Gastrointestinal-Oncology
Esophageal Adenocarcinoma Biomarkers: HER2, PD-L1, MSI, CLDN18.2 and Emerging Targets

Esophageal Adenocarcinoma Biomarkers: HER2, PD-L1, MSI, CLDN18.2 and Emerging Targets

Esophageal Squamous Cell Carcinoma Biomarkers: PD-L1, Molecular Features and Emerging Targets

Ziihera Plus Chemotherapy Improves Overall Survival in First-Line HER2-Positive Locally Advanced or Metastatic Gastroesophageal Adenocarcinoma

Phase 2 NEST Trial: Neoadjuvant BOT/BAL in Localized Colon Cancer

FDA Approves Daraxonrasib: First-in-Class RAS Inhibitor for Metastatic Pancreatic Cancer

SKYSCRAPER-07: Atezolizumab ± Tiragolumab After dCRT in Unresectable ESCC

TALENTOP: Liver Resection After Atezolizumab and Bevacizumab in Locally Advanced HCC

Breast-Oncology
Camizestrant

FDA Grants Accelerated Approval to Camizestrant for ESR1-Mutated Advanced Breast Cancer

Stage I TNBC Is Not One Risk Group: Can Immune Biology Identify Patients Who Need Less Treatment?

When Bone-Only HR+/HER2− Breast Cancer Turns Visceral: What PR Expression May Tell Us in the CDK4/6 Era

Enhertu Plus Pertuzumab Approved in the EU for First-Line HER2-Positive Metastatic Breast Cancer: A New Benchmark After More Than a Decade

Trastuzumab deruxtecan Plus Pertuzumab Approved in EU for First-Line HER2-Positive Metastatic Breast Cancer

Iza-Bren Reaches the Phase III PFS Endpoint in HR+/HER2− Advanced Breast Cancer: Why PANKU-Breast01 Matters

ctDNA During Neoadjuvant Therapy: Toward Real-Time Risk Stratification in Early Breast Cancer

Lung-Oncology
Lung Cancer

Exercise in Lung Cancer Care: From Supportive Evidence to Global Implementation With IREX-Lung

Daraxonrasib Opens a Broader RAS-Targeting Strategy in Previously Treated NSCLC

SANOVO: Osimertinib Plus Savolitinib Moves MET-Directed Therapy Into First-Line EGFR-Mutated NSCLC

XPO1 Inhibition May Reprogram Immune Resistance in SCLC: The TRIM21–IRF3–TNFSF15–TREM2 Axis

AstraZeneca Completes Zegfrovy Deal for EGFR Exon 20 Insertion NSCLC

Adjuvant Crizotinib Fails in Resected ALK-Positive NSCLC: What E4512 Tells Us About Targeted Therapy in Early Disease

7 Powerful Advances in the ASCO 2026 Guideline for Driver-Positive Stage IV NSCLC

OncoDaily TV
Cancer Care

Personalizing Colorectal Cancer Care with ctDNA? Dr. Robert Lentz

Priti Patnaik, Independent journalism

Independent journalism in global health: Priti Patnaik

Treatment Paradigms, Karine Tawagi

Evolving Treatment Paradigms in Muscle-Invasive Bladder Cancer

Cancer in Women

Cancer in Women As a Global Health and Economic Issue: Dr. Maira Caleffi

oncoffee, palliative

ONCOFFEE: Colorectal Cancer, Palliative Care, and the Human Side of Oncology: Santiago Fontes

Empowering Oncologists

Empowering Oncologists: How Policy impacts Medicine?

WHO

Mission is possible: WHO said 2030 – Rwanda said 2027: Dr. Sabin Nsanzimana

Current Landscape

The Current Landscape and Future of CAR-T in Aggressive B-Cell Lymphoma

Experts by Experience

Experts by Experience with Carmen Monge

Fighting Cervical Cancer

From Engineering to Fighting Cervical Cancer

Dr. Beatrice Addai Wiafe

Fighting Cancer With Peace And Love: Dr. Beatrice Addai Wiafe

Maggie Smith breast cancer

Dame Maggie Smith and Courageus Breast Cancer Journey: Filming Harry Potter During Chemotherapy

Not To Miss
Gevorg Tamamyan

OncoDaily Editor-in-Chief Gevorg Tamamyan Awarded 2026 Global Health Catalyst Distinguished Leader Award

Highlights From LeukO 2026: Global Virtual Congress on Leukemias, Day 2

FDA Grants Accelerated Approval to Camizestrant for ESR1-Mutated Advanced Breast Cancer

TG4050 Neoantigen Vaccine Shows 100% Three-Year Disease-Free Survival in Phase 1 Head and Neck Cancer Trial

Highlights From LeukO 2026: Global Virtual Congress on Leukemias, Day 1

Etentamig Improves Response Rate and PFS in Phase 3 CERVINO Multiple Myeloma Trial

HUTCHMED and GSK Sign Up to $1.295B Licensing Deal for KRAS-EGFR Cancer Therapy HMPL-A830

OncoGrants
Surgical Oncology

ESSO Educational Grants for Surgical Oncology 2026

Medical Oncology Fellowship

Melanoma Institute Australia Immuno-Oncology / Medical Oncology Fellowship 2028

Y-ESSO Research

Y-ESSO Research Grants for Young Surgical Oncologists 2026

Glioblastoma Therapeutics

NCI Glioblastoma Therapeutics Network U19 Grant 2026

CRI

CRI Irvington Postdoctoral Cancer Research Fellowship (March 2027 Cycle)

Pathway to Independence Award

NCI Pathway to Independence Award for Early-Stage Postdoctoral Researchers 2026

Oncologist near me
Oncologist Near Me

Oncologist Near Me – Gregory Kalemkerian: Advancing Lung Cancer Care, Research, and Education
Oncologist Near Me

Oncologist Near Me – Nagashree Seetharamu: A Journey of Healing, Mentorship, and Leadership
Oncologist Near Me

Oncologist Near Me – Paolo Tarantino: Shaping the Future of Breast Cancer Treatment
Oncologist Near Me

Oncologist Near Me – Rana McKay: A Rising Force in Genitourinary Cancer Research and Care
Oncologist Near Me

Oncologist Near Me – Razelle Kurzrock: Revolutionizing Cancer Treatment Through Precision Medicine
Oncologist Near Me

Oncologist Near Me – Yelena Janjigian: A Global Leader in Gastrointestinal Oncology
Oncologist Near Me

Oncologist Near Me – Bishal Gyawali: Challenging the Status Quo in Global Oncology
Oncologist Near Me

Oncologist Near Me – Yan Leyfman: A Voice for Innovation, Mentorship, and Impact in Oncology
Oncologist Near Me

Oncologist Near Me – Wafik S. El-Deiry: A Global Leader in Translational Oncology and Cancer Research
Oncologist Near Me

Oncologist Near Me – Enrique Soto: A Leader in Geriatric Oncology and Global Cancer Care

Cancer types
Non-Hodgkin Lymphoma NHL, DLBCL

Non-Hodgkin Lymphoma (NHL): A Practical Biological Map and Integrative Overview

Mantle Cell Lymphoma (MCL): Revealing the Biology Beneath the Mantle and Modern Therapeutic Frontiers

Burkitt Lymphoma: Among the Fastest Growing Yet Most Curable Human Cancers

Diffuse Large B-Cell Lymphoma (DLBCL): Molecular Heterogeneity and Progress in Therapy

Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN): Current Perspectives on an Ultra-Rare Malignancy

Richter Transformation (RT): When Chronic Lymphocytic Leukemia Turns Aggressive

Acute Myeloid Leukemia (AML) in 2026: The Current Landscape and Future Perspectives

CancerWorld

Oncologists
Siddharth Sreemahadevan

Siddharth Sreemahadevan

Oncologists Location Thalassery, India
Maite Gorostegui Obanos

Maite Gorostegui Obanos

Oncologists Location Barcelona, Spain
Hesham ElGhazaly

Hesham ElGhazaly

Oncologists Location Cairo, Egypt
Gabriëlle van Ramshorst

Gabriëlle van Ramshorst

Oncologists Location Ghent, Belgium
Ninad Katdare

Ninad Katdare

Oncologists Location Mumbai, India
Jalid Sehouli

Jalid Sehouli

Oncologists Location Berlin, Germany
Rana McKay

Rana R. McKay

Oncologists Location San Diego, USA
Edoardo Francini

Edoardo Francini

Oncologists Location Florence, Italy

Oncology Drugs
OTX-2002: Innovative MYC-Targeting mRNA Therapy, Dose, Administration, and Clinical Trials

OTX-2002: Innovative MYC-Targeting mRNA Therapy, Dose, Administration, and Clinical Trials

mRNA-4359: Promising Cancer Vaccine, Dose, Administration, and Clinical Trials

BXCL701: Promising Innate Immune Activation, Dose, Administration, And Clinical Trials

NBTXR3: Promising Radioenhancer, Administration, Dose, And Clinical Trials

KT-333: Promising STAT3 Degradation, Dose, Administration, And Clinical Trials

Veliparib: Mechanism, Dose, Administration, And Clinical Trials

Adavosertib: Mechanism, Dose, Administration, And Clinical Trials

OncoDaily Magazine

New Paper Alert
Kefah Mokbel

Kefah Mokbel: ctDNA Identifies Patients at Risk of Breast Cancer Relapse

Alberto Puccini, Humanitas University

Alberto Puccini: Long Non-Coding RNAs Open New Directions in Colorectal Cancer

Wen Jiang

Wen Jiang: Translational Challenges and Opportunities in mRNA Cancer Vaccines

Victor Moreno

Victor Moreno: Rethinking What Phase 1 Means in Modern Oncology Trials

Rik Bryan

Rik Bryan: New Data Highlight the Potential of the GALEAS Bladder Test

Erika Hamilton

Erika Hamilton: Addressing Depression and Stress in Cancer Survivors

OncoDaily Medical Journal

Pediatric Oncology

10.69690/ODMJ-011-0826-7849

Integrated Management of Endo and Exo-pelvic Sacrococcygeal Teratomas (Altman type III): Report of Two Cases
Case Reports & Case Series

GI Oncology

10.69690/ODMJ-018-0826-7959

From Plate to Polyps: Dietary N-Nitrosamines and Biomarkers of DNA Damage
Abstracts

Head and Neck Cancer

10.69690/ODMJ-018-0826-7933

A Service Review of PD-L1 Biomarker Use in the Head and Neck Cancer Service
Abstracts

Radiation Oncology

10.69690/ODMJ-018-0826-7920

Short-Course Palliative Radiotherapy for Tumour-Related Bleeding in End-of-Life Care: A Focused Literature Review
Abstracts

Pediatric Oncology

10.69690/ODMJ-018-0826-7952

FLASH radiotherapy: A Potential Way to Protect the Developing Brain in Pediatric Oncology
Abstracts

GI Oncology

10.69690/ODMJ-018-0826-7947

Real World Clinical Insights in Combination of Trifluridine-Tipiracil with Bevacizumab for Metastatic Colorectal Cancer
Abstracts

Hematology

10.69690/ODMJ-018-0826-7945

Plasma cell survival: The impact of extracellular ATP
Abstracts

Breast Cancer

10.69690/ODMJ-018-0826-7965

A Systematic Comparison of ICG Fluorescence vs Dual-Tracer Sentinel Lymph Node Biopsy in Breast Cancer Staging
Abstracts